These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 30792527)
1. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation. Mir H; Kaur G; Kapur N; Bae S; Lillard JW; Singh S Sci Rep; 2019 Feb; 9(1):2527. PubMed ID: 30792527 [TBL] [Abstract][Full Text] [Related]
2. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways. Han J; Fu R; Chen C; Cheng X; Guo T; Huangfu L; Li X; Du H; Xing X; Ji J Int J Biol Sci; 2021; 17(11):2841-2852. PubMed ID: 34345211 [TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16/CXCR6 expression. Hong L; Wang S; Li W; Wu D; Chen W Pathol Res Pract; 2018 Sep; 214(9):1345-1351. PubMed ID: 30049511 [TBL] [Abstract][Full Text] [Related]
4. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. Guo L; Cui ZM; Zhang J; Huang Y Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1. Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403 [TBL] [Abstract][Full Text] [Related]
6. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity. Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602 [TBL] [Abstract][Full Text] [Related]
7. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases. Korbecki J; Bajdak-Rusinek K; Kupnicka P; Kapczuk P; Simińska D; Chlubek D; Baranowska-Bosiacka I Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800554 [TBL] [Abstract][Full Text] [Related]
8. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition. Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473 [TBL] [Abstract][Full Text] [Related]
9. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro. Hu W; Liu Y; Zhou W; Si L; Ren L PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301 [TBL] [Abstract][Full Text] [Related]
10. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma. Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X Gene; 2019 Sep; 713():143969. PubMed ID: 31299360 [TBL] [Abstract][Full Text] [Related]
11. CXCL16/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K/AKT/FOXO3a pathway. Ma Z; Yu R; Zhu Q; Sun L; Jian L; Wang X; Zhao J; Li C; Liu X Int Immunopharmacol; 2020 Apr; 81():106035. PubMed ID: 31753588 [TBL] [Abstract][Full Text] [Related]
12. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16. Adamski V; Mentlein R; Lucius R; Synowitz M; Held-Feindt J; Hattermann K Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698473 [TBL] [Abstract][Full Text] [Related]
13. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989 [TBL] [Abstract][Full Text] [Related]
15. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases. Mir H; Singh R; Kloecker GH; Lillard JW; Singh S Oncotarget; 2015 Apr; 6(12):9985-98. PubMed ID: 25888629 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel. Kapur N; Mir H; Sonpavde GP; Jain S; Bae S; Lillard JW; Singh S Cancer Lett; 2019 Jul; 454():1-13. PubMed ID: 30974114 [TBL] [Abstract][Full Text] [Related]
17. Genetic diversification of chemokine CXCL16 and its receptor CXCR6 in primates. Xu F; He D; Liu J; Ni Q; Lyu Y; Xiong S; Li Y Dev Comp Immunol; 2018 Aug; 85():86-94. PubMed ID: 29635005 [TBL] [Abstract][Full Text] [Related]
18. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560 [TBL] [Abstract][Full Text] [Related]
19. Activation of the CXCL16/CXCR6 Axis by TNF-α Contributes to Ectopic Endometrial Stromal Cells Migration and Invasion. Peng Y; Ma J; Lin J Reprod Sci; 2019 Mar; 26(3):420-427. PubMed ID: 29779473 [TBL] [Abstract][Full Text] [Related]
20. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis. Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]